Written by Chrystal Moulton, Staff Writer. Treatment of malignant pleural mesothelioma with genetically engineered virus improves survival time by 18 months in Phase 1 trial. In a case study of a 68-year old male with malignant pleural mesothelioma (1), researchers...
Artichoke Leaf Extract in the Treatment of Pleural Mesothelioma
Written by Joyce Smith, BS. Treatment of malignant pleural mesothelioma cells with artichoke leaf extract significantly decreased cell growth and proliferation and increased apoptosis (cell death). There is presently no diagnostic tool that allows for early diagnosis...
Malignant Pleural Mesothelioma: My Personal Story – Informed Opinion
Written by Elwood Richard, BS. A touching article by Elwood Richard, who developed malignant pleural mesothelioma from asbestos exposure as a young man. Recently I have been diagnosed with mesothelioma, a disease caused by exposure to asbestos. My only exposure was...
Possible Biomarker for Pleural Mesothelioma Found
Written by Chrystal Moulton, Staff Writer. Study shows B7-H1 could serve as a biomarker for early detection of malignant pleural mesothelioma. In the current research, B7 homolog 1 also known as programmed cell death ligand 1 (PDL-1) was tested on samples of patients...
NGR-hTNF Treatment for Malignant Pleural Mesothelioma
Written by Joyce Smith, BS. NGR-hTNF has low toxicity and potential as a treatment for malignant pleural mesothelioma when used in combination with chemotherapeutic agents. Tumor necrosis factor (TNFα) is one of multiple proteins capable of inducing necrosis (death)...